Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom

Whyte, S., Cooper, K..L, Stevenson, M.D. et al. (2 more authors) (2011) Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom. HEDS Discussion Paper , 11-01.

Abstract

Metadata

Authors/Creators:
  • Whyte, S. (sophie.whyte@sheffield.ac.uk)
  • Cooper, K..L (k.l.cooper@sheffield.ac.uk)
  • Stevenson, M.D. (m.d.stevenson@sheffield.ac.uk)
  • Madan, J.
  • Akehurst, R. (r.l.akehurst@sheffield.ac.uk)
Keywords: cost-effectiveness; economic model; febrile neutropenia; granulocyte colony–stimulating factors; prophylaxis
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Health Economics and Decision Science > HEDS Discussion Paper Series
Depositing User: ScHARR / HEDS (Sheffield)
Date Deposited: 11 Jul 2012 09:17
Last Modified: 05 Jun 2014 23:41
Status: Published

Download

Filename: HEDS-DP-11-01.pdf

Share / Export